Insertable cardiac monitors significantly enhance atrial fibrillation detection in patients with cryptogenic stroke, achieving detection rates of approximately 41% within six months post-implantation.
Do insertable cardiac monitors improve the detection of occult atrial fibrillation in patients with cryptogenic stroke compared to traditional short-term monitoring?
This review highlights the clinical value of insertable cardiac monitors for detecting occult atrial fibrillation in cryptogenic stroke patients, enabling targeted anticoagulation to prevent recurrent strokes.
Cryptogenic stroke, a subtype of ischemic stroke with no identifiable cause after comprehensive evaluation, presents a unique challenge in stroke prevention. Atrial fibrillation (AF), a common risk factor for ischemic stroke, is often underdiagnosed in these patients due to its intermittent, asymptomatic nature. Early detection of AF is critical, as anticoagulation therapy significantly reduces the risk of recurrent stroke in AF patients. However, traditional short-term monitoring methods frequently fail to identify paroxysmal AF. Insertable cardiac monitors (ICMs) offer a novel solution by providing continuous, long-term heart rhythm monitoring, which has proven effective in detecting occult AF. Real-world data further support the clinical value of ICMs in guiding the initiation of anticoagulation therapy, ultimately improving stroke prevention strategies. Despite some limitations, such as false positives and the invasive nature of the device, ICMs have emerged as a critical tool in modern stroke management. As technology evolves, future advancements may further enhance AF detection by integrating artificial intelligence and wearable devices. This review provides a comprehensive overview of the role of AF in cryptogenic stroke, the importance of early detection, and the growing significance of ICMs in clinical practice.
Khan et al. (Sat,) conducted a review in Cryptogenic stroke and atrial fibrillation. Insertable cardiac monitors (ICMs) vs. Traditional short-term monitoring methods was evaluated on Detection of atrial fibrillation. Insertable cardiac monitors significantly enhance atrial fibrillation detection in patients with cryptogenic stroke, achieving detection rates of approximately 41% within six months post-implantation.